Simultaneous Realization of Multilayer Interphases on a Ni-Rich NCM Cathode and a SiOx Anode by the Combination of Vinylene Carbonate with Lithium Difluoro(oxalato)borate.

Ni-rich NCM and SiOx electrode materials have garnered the most attention for advanced lithium-ion batteries (LIBs); however, severe parasitic reactions occurring at their interfaces are critical bottlenecks in their widespread application. In this study, an effective additive combination (VL) composed of vinylene carbonate (VC) and lithium difluoro(oxalato)borate (LiDFOB) is proposed for both Ni-rich NCM and SiOx electrode materials. The LiDFOB additive individually delivers inorganic-rich cathode-electrolyte interphase (CEI) and solid-electrolyte interphase (SEI) layers in anodic and cathodic polarizations before the VC additive. Subsequently, the VC additive is capable of the formation of additional CEI and SEI layers composed of relatively organic-rich components through an electrochemical reaction; thus, inorganic-organic hybridized CEI and SEI layers are simultaneously formed at the Ni-rich NCM and SiOx electrodes. Accordingly, the VL-assisted electrolyte exhibits remarkably prolonged cycling retention for the Ni-rich NCM cathode (86.5%) and SiOx anode (72.7%), whereas the standard electrolyte shows a substantial decrease in cycling retention for the Ni-rich NCM cathode (59.2%) and SiOx anode (18.1%). Further systematic analyses prove that VL-assisted electrolytes form effective interphases for Ni-rich NCM and SiOx electrodes simultaneously, thereby leading to stable and prolonged cycling behaviors of LIBs that offer high energy densities.

An Ultralow-concentration and Moisture-resistant Electrolyte of Lithium Difluoro(oxalato)borate in Carbonate Solvents for Stable Cycling in Practical Lithium-ion Batteries.

The electrolyte concentration not only impacts the battery performance but also affects the battery cost and manufacturing. Currently, most studies focus on high-concentration (>3 M) or localized high-concentration electrolytes (~1 M); however, the expensive lithium salt imposes a major concern. Most recently, ultralow concentration electrolytes (<0.3 M) have emerged as intriguing alternatives for battery applications, which feature low cost, low viscosity, and extreme-temperature operation. However, at such an early development stage, many works are urgently needed to further understand the electrolyte properties. Herein, we introduce an ultralow concentration electrolyte of 2 wt % (0.16 M) lithium difluoro(oxalato)borate (LiDFOB) in standard carbonate solvents. This electrolyte exhibits a record-low salt/solvent mass ratio reported to date, thus pointing to a superior low cost. Furthermore, this electrolyte is highly compatible with commercial Li-ion materials, forming stable and inorganic-rich interphases on the lithium cobalt oxide (LiCoO2) cathode and graphite anode. Consequently, the LiCoO2-graphite full cell demonstrates excellent cycling performance. Besides, this electrolyte is moisture-resistant and effectively suppresses the generation of hydrogen fluoride, which will markedly facilitate the battery assembly and recycling process under ambient conditions.

Oxalate nephropathy and chronic turmeric supplementation: a case report / Nefropatia por oxalato e suplementação crônica de cúrcuma: relato de caso

ABSTRACT We present a case of a 69-year-old man who presented for routine check-up and was incidentally found to have kidney failure with an initially unrevealing history and bland urinary sediment. He was diagnosed with oxalate nephropathy in the setting of chronic turmeric supplementation and chronic antibiotic therapy with associated diarrhea. Our case provides several key insights into oxalate nephropathy. First, the diagnosis requires a high index of clinical suspicion. It is uncommonly suspected clinically unless there is an obvious clue in the history such as Roux-en-Y gastric bypass or ethylene glycol poisoning. Diagnosis can be confirmed by histopathologic findings and corroborated by serum levels of oxalate and 24-hour urinary excretion. Second, the diagnosis can often be missed by the pathologist because of the characteristics of the crystals unless the renal pathologist has made it a rule to examine routinely all H&E sections under polarized light. This must be done on H&E, as the other stains dissolve the crystals. Third, one oxalate crystal in a routine needle biopsy is considered pathologic and potentially contributing to the AKI or to the CKD in an important way. Fourth, secondary oxalosis can be largely mitigated or prevented in many cases, especially iatrogenic cases. This can come through the surgeon or the gastroenterologist providing proper instructions to patients on an oxalate-restricted diet or other specific dietary measures. Lastly, this case highlights the success that results from cooperation and communication between the pathologist and the treating physician.

RESUMO Relatamos o caso de um homem de 69 anos que se apresentou para exame de rotina e descobriu-se incidentalmente que ele tinha insuficiência renal, com histórico inicialmente não revelador e sedimento urinário brando. Ele foi diagnosticado com nefropatia por oxalato no contexto de suplementação crônica de cúrcuma e antibioticoterapia crônica com diarreia associada. Nosso caso fornece diversas sugestões importantes sobre nefropatia por oxalato. Primeiro, o diagnóstico requer elevado índice de suspeita clínica. A suspeita clínica é incomum, a menos que haja evidência óbvia no histórico, como bypass gástrico em Y de Roux ou envenenamento por etilenoglicol. O diagnóstico pode ser confirmado por achados histopatológicos e corroborado por níveis séricos de oxalato e excreção urinária de 24 horas. Segundo, o diagnóstico pode passar despercebido pelo patologista devido às características dos cristais, a menos que o patologista renal estabeleça como regra examinar rotineiramente todas as seções coradas com H&E sob luz polarizada. Isso deve ser feito com H&E, pois, outras colorações dissolvem os cristais. Em terceiro lugar, um cristal de oxalato em biópsia por agulha de rotina é considerado patológico, contribuindo potencialmente para LRA ou para DRC de maneira significativa. Em quarto lugar, a oxalose secundária pode ser amplamente mitigada ou prevenida em muitos casos, especialmente casos iatrogênicos. Isso pode ser feito pelo cirurgião ou pelo gastroenterologista, fornecendo instruções adequadas aos pacientes sobre uma dieta restrita em oxalato ou outras medidas dietéticas específicas. Por fim, esse caso destaca o sucesso que resulta da cooperação e comunicação entre o patologista e o médico assistente.

Tratamiento farmacológico de la litiasis renal: medicamentos actuales y monitorización del pH urinario / Pharmacologic treatment of kidney stones: Current medication and pH monitoring

La nefrolitiasis es una enfermedad urológica de prevalencia mundial asociada a una importante morbilidad y malestar para el paciente. El tratamiento actual de los cálculos renales se basa en intervenciones quirúrgicas y farmacológicas. Aunque la cirugía puede ser necesaria en casos determinados, el tratamiento farmacológico es una opción más asequible, fácilmente disponible y menos invasiva para el paciente. Se realizó una revisión exhaustiva para resumir la bibliografía disponible sobre las estrategias de manejo farmacológico de los principales tipos de litiasis: oxalato cálcico, fosfato cálcico, ácido úrico, estruvita y cistina. La regulación de factores como el pH urinario, la cristalización de los cálculos y los trastornos metabólicos del paciente que precipitan el desarrollo y el crecimiento de los cálculos es fundamental para estos enfoques terapéuticos. Esta revisión hace hincapié en las opciones farmacológicas disponibles para el tratamiento según el tipo de litiasis y destaca la importancia de un tratamiento médico personalizado para cada paciente, aspecto que debe ser tenido en cuenta por todos los médicos. (AU)

Nephrolithiasis is a globally prevalent urologic condition associated with significant morbidity and patient discomfort. Current management of kidney stones includes both surgical and pharmacologic interventions. Though surgery may be necessary under certain circumstances, pharmacologic treatment is a more affordable, readily available, and a less invasive option for patients. A comprehensive scoping review was conducted to summarize the available literature on the pharmacologic strategies for managing the predominant stone types including calcium oxalate, calcium phosphate, uric acid, struvite, and cystine stones. Central to these therapeutic approaches is the regulation of factors such as urine pH, stone crystallization, and patient metabolics that precipitate stone development and growth. This review highlights the pharmacological options available for treating each kidney stone type, emphasizing the importance of patient tailored medical management that should be considered by every physician. (AU)

Constructing Matching Cathode-Anode Interphases with Improved Chemo-mechanical Stability for High-Energy Batteries.

Coupling Ni-rich layered oxide cathodes with Si-based anodes is one of the most promising strategies to realize high-energy-density Li-ion batteries. However, unstable interfaces on both cathode and anode sides cause continuous parasitic reactions, resulting in structural degradation and capacity fading of full cells. Herein, lithium tetrafluoro(oxalato) phosphate is synthesized and applied as a multifunctional electrolyte additive to mitigate irreversible volume swing of the SiOx anode and suppress undesirable interfacial evolution of the LiNi0.83Co0.12Mn0.05O2 (NCM) cathode simultaneously, resulting in improved cycle life. Benefiting from its desirable redox thermodynamics and kinetics, the molecularly tailored additive facilitates matching interphases consisting of LiF, Li3PO4, and P-containing macromolecular polymer on both the NCM cathode and SiOx anode, respectively, modulating interfacial chemo-mechanical stability as well as charge transfer kinetics. More encouragingly, the proposed strategy enables 4.4 V 21700 cylindrical batteries (5 Ah) with excellent cycling stability (92.9% capacity retention after 300 cycles) under practical conditions. The key finding points out a fresh perspective on interfacial optimization for high-energy-density battery systems.

Improved Interface Construction on Anode and Cathode for Na-Ion Batteries Using Ultralow-Concentration Electrolyte Containing Dual-Additives.

Compared with Li+, Na+ with a smaller stokes radius has faster de-solvation kinetics. An electrolyte with ultralow sodium salt (0.3 M NaPF6) is used to reduce the cell cost. However, the organic-dominated interface, mainly derived from decomposed solvents (SSIP solvation structure), is defective for the long cycling performance of sodium ion batteries. In this work, the simple application of dual additives, including sodium difluoro(oxalato)borate (NaDFOB) and tris(trimethylsilyl)borate (TMSB), is demonstrated to improve the cycling performance of the hard carbon/NaNi1/3Fe1/3Mn1/3O2 cell by constructing interface films on the anode and cathode. A significant improvement on cycling stability has been achieved by incorporating dual additives of NaDFOB and TMSB. Particularly, the capacity retention increased from 17 % (baseline) to 79 % (w/w, 2.0 wt % NaDFOB) and 83 % (w/w, 2.0 wt % NaDFOB and 1.0 wt % TMSB) after 200 cycles at room temperature. Insight into the mechanism of improved interfacial properties between electrodes and electrolyte in ultralow concentration electrolyte has been investigated through a combination of theoretical computation and experimental techniques.

Fluorine-Free Lithium-Ion Capacitor with Enhanced Sustainability and Safety Based on Bio-Based Æ´-Valerolactone and Lithium Bis(Oxalato)Borate Electrolyte.

In this work, the properties of a novel electrolyte based on the combination of bio-based Æ´-valerolactone (GVL) solvent with lithium bis(oxalato)borate (LiBOB) salt and its use for lithium-ion capacitors (LICs) are presented. It is shown that the 1 m LiBOB in GVL electrolyte displays good transport properties, high thermal stability, and the ability to prevent anodic dissolution. Its impact on the performance of both battery-type and capacitive-type electrodes is evaluated. In this regard, special attention is paid to the filming properties associated with LiBOB and GVL decomposition at the electrode surfaces. To the best of the authors' knowledge, the full-cell devices assembled in this study are the first example of a fluorine-free LIC. These devices exhibit a favorable energy-to-power ratio, delivering 80 Wh kg-1 AM at 10 000 W kg-1 AM along with excellent cycling stability, retaining 80% of the initial capacitance after 25 000 cycles. Furthermore, post-mortem analysis of the LIC electrodes is conducted to gain deeper insights into the degradation mechanisms within the device.

Pharmacologic treatment of kidney stones: Current medication and pH monitoring.

Nephrolithiasis is a globally prevalent urologic condition associated with significant morbidity and patient discomfort. Current management of kidney stones includes both surgical and pharmacologic interventions. Though surgery may be necessary under certain circumstances, pharmacologic treatment is a more affordable, readily available, and a less invasive option for patients. A comprehensive scoping review was conducted to summarize the available literature on the pharmacologic strategies for managing the predominant stone types including calcium oxalate, calcium phosphate, uric acid, struvite, and cystine stones. Central to these therapeutic approaches is the regulation of factors such as urine pH, stone crystallization, and patient metabolics that precipitate stone development and growth. This review highlights the pharmacological options available for treating each kidney stone type, emphasizing the importance of patient tailored medical management that should be considered by every physician.

Synthesis and crystal structure of hydrated µ-oxa-lato-bis-{bis-[3-methyl-5-(pyridin-2-yl)-1H-1,2,4-triazole]iron(II)} bis-(toluene-sulfonate) 2.75-hydrate.

In the title compound [Fe2(C2O4)(C8H8N4)4](CH3C6H4SO3)2·2.75H2O, the two FeII ions have a highly distorted octa-hedral FeN4O2 environment formed by two bidentate triazole-based chelating ligands and a bis-bidentate oxalate bridging anion that connects the metal ions. Stabilization within the crystal structure is provided via a system of O-H⋯O and N-H⋯O hydrogen bonding, which determines the formation of a two-dimensional architecture along the a-axis direction.

Halide-Free Synthesis of New Difluoro(oxalato)borate [DFOB]- -Based Ionic Liquids and Organic Ionic Plastic Crystals.

The implementation of next-generation batteries requires the development of safe, compatible electrolytes that are stable and do not cause safety problems. The difluoro(oxalato)borate ([DFOB]- ) anion has been used as an electrolyte additive to aid with stability, but such an approach has most commonly been carried out using flammable solvent electrolytes. As an alternative approach, utilisation of the [DFOB]- anion to make ionic liquids (ILs) or Organic Ionic Plastic Crystals (OIPCs) allows the advantageous properties of ILs or OIPCs, such as higher thermal stability and non-volatility, combined with the benefits of the [DFOB]- anion. Here, we report the synthesis of new [DFOB]- -based ILs paired with triethylmethylphosphonium [P1222 ]+ , and diethylisobutylmethylphosphonium [P122i4 ]+ . We also report the first OIPCs containing the [DFOB]- anion, formed by combination with the 1-ethyl-1-methylpyrrolidinium [C2 mpyr]+ cation, and the triethylmethylammonium [N1222 ]+ cation. The traditional synthetic route using halide starting materials has been successfully replaced by a halide-free tosylate-based synthetic route that is advantageous for a purer, halide free product. The synthesised [DFOB]- -based salts exhibit good thermal stability, while the ILs display relatively high ionic conductivity. Thus, the new [DFOB]- -based electrolytes show promise for further investigation as battery electrolytes both in liquid and solid-state form.

Extraction and quantification of oxalic acid in leaves of plant species used in the treatment of chronic non-communicable diseases / Extracción y cuantificación de ácido oxálico en hojas de especies vegetales utilizadas en el tratamiento de enfermedades crónicas no transmisibles / Extração e quantificação de ácido oxálico em folhas de espécies vegetais utilizadas no tratamento de doenças crônicas nã transmissíveis

RESUMEN Introducción: Las enfermedades crónicas no transmisibles (ECNT) tienen las tasas de mortalidad y morbilidad más altas del mundo. El uso de plantas medicinales en la terapia de estas enfermedades es una realidad muy extendida. Sin embargo, la mayoría de las especies vegetales contienen cristales de oxalato cálcico, producto del metabolismo vegetal y su ingesta se correlaciona con la aparición de problemas renales como la litiasis urinaria, especialmente en personas predispuestas a estas afecciones. Objetivo: Determinar la cantidad de ácido oxálico en especies vegetales que se utilizan en el tratamiento de las ECNT. Metodología: Se obtuvieron extractos acuosos y ácidos de 0,5 g del fármaco vegetal de la especie y, posteriormente, se tituló con una solución estandarizada de permanganato de potasio 0,02 mol.L-1con las concentraciones de ácido oxálico expresadas en g/100g de fármaco vegetal seco. Resultados: La concentración de ácido oxálico osciló entre 4,58 ± 0,09 g/100 g a 17,21 ± 0,07 g/100 g en especies de plantas y la extracción de ácido fue más eficiente. Se realizó una optimización metodológica para las especies que presentaron los mejores resultados, Psidiumguajava y Artocarpus heterophyllus. Conclusión: Los datos obtenidos pueden servir de base para decisiones médicas y para profesionales que prescriben plantas medicinales.

SUMMARY Introduction: Chronic non-communicable diseases (CNCDs) are a group of diseases characterized by having the highest mortality and morbidity rates in the world. Despite the increase in new drug technologies, the use of medicinal plants as an aid in therapy for these diseases is a widespread reality. However, most plant species contain inorganic crystals of calcium oxalate, a product of plant metabolism, which has several functions in plant tissues. For the human species, its ingestion is associated with the arising of kidney problems such as urinary lithiasis, especially in people who have a predisposition to these conditions. Aim: To determine the amount of oxalic acid in plant species, which are used in the treatment of CNCDs. Methodology: After collection and characterization the plant species, aqueous and acidic extracts were obtained from 0.5 g of the plant drug of each species and, subsequently, were titrated with a standardized 0.02 mol.L-1 potassium permanganate solution and the concentrations of oxalic acid were expressed in g/100 g of dry vegetable drug. Result: The data obtained from the concentration of oxalic acid ranged from 4.58 ± 0.09 g/100 g to 17.21 ± 0.07 g/100 g and demonstrated that the concentrations from acid extraction are higher compared to the aqueous extraction, for all vegetables species analyzed. Methodological optimization was performed for the species that showed the highest results, Psidium guajava and Artocarpus hetero phyllus. Conclusion: The data obtained can serve as input for medical decisions and for professionals who prescribe medicinal plants.

RESUMO Introdução: As doenças crônicas não transmissíveis (DCNT) são um grupo de doenças caracterizadas por apresentar as maiores taxas de mortalidade e morbidade do mundo. Apesar do aumento de novas tecnologias medicamentosas, o uso de plantas medicinais como auxiliar na terapia dessas doenças é uma realidade bastante difundida. No entanto, a maioria das espécies vegetais contém cristais inorgânicos de oxalato de cálcio, um produto do metabolismo vegetal, que possui diversas funções nos tecidos vegetais. Para a espécie humana, sua ingestão está associada ao surgimento de problemas renais como a litíase urinária, principalmente em pessoas com predisposição a essas condições. Objetivo: Determinar a quantidade de ácido oxálico em espécies vegetais, que são utilizadas no tratamento de DCNT. Metodologia: Após a coleta e caracterização das espécies vegetais, extratos aquosos e ácidos foram obtidos a partir de 0,5 g da droga vegetal de cada espécie e, posteriormente, titulados com solução padronizada de permanganato de potássio 0,02 mol.L-1 e as concentrações de ácido oxálico foram expressos em g/100 g de fármaco vegetal seco. Resultado: Os dados obtidos da concentração de ácido oxálico variaram de 4,58 ± 0,09 g/100 g a 17,21 ± 0,07 g/100 g e demonstraram que as concentrações da extração ácida são maiores em relação à extração aquosa, para todas as espécies vegetais analisadas. A otimização metodológica foi realizada para as espécies que apresentaram os maiores resultados, Psidiumguajava e Artocarpus heterophyllus. Conclusão: Os dados obtidos podem servir de subsídio para decisões médicas e para profissionais que prescrevem plantas medicinais.

Caracterización clínico-epidemiológica de la urolitiasis / Clinical-epidemiological description of urolithiasis

Introducción: Las urolitiasis ocasionan dolor, deterioro funcional renal y notorias erogaciones económicas. Objetivos: Identificar las características clínico-epidemiológicas de la nefrolitiasis. Métodos: Estudio descriptivo, transversal. Se estudiaron 2 923 personas pertenecientes a tres consultorios del Policlínico Plaza; municipio Plaza de la Revolución, provincia La Habana, Cuba., seleccionados por muestreo simple aleatorio de los 16 con que cuenta el área de salud. Los datos se obtuvieron mediante encuesta y entrevista estructurada. La información fue procesada de forma automatizada (IBMSPSS 22.0). Se utilizó análisis de distribución de frecuencias, se calcularon tasas de prevalencia, y fue empleado el test de homogeneidad. Resultados: La prevalencia de urolitiasis fue de 4,99 por cada 100 habitantes, de 6,3 entre los varones y de 5,7 en los de piel blanca. La edad promedio al diagnóstico fue de 39,3 años. Entre los factores de riesgo de litiasis predominó la alta ingestión de oxalatos (97,3 por ciento). La ecografía fue la forma de diagnóstico más usada (67,8 por ciento). La fitoterapia fue el tratamiento médico más utilizado (69,2 por ciento). Al 16,4 por ciento de los pacientes se les expidió certificado médico en los últimos dos años. Conclusiones: La prevalencia de litiasis urinaria en el Policlínico Docente Plaza de la Revolución es elevada, con predominio en el sexo masculino, en sujetos de piel blanca y en las edades medias de la vida. La alta ingestión de oxalato es el factor de riesgo de litiasis urinaria más frecuente encontrado. La forma de diagnóstico más utilizada es la ecografía y el tratamiento más empleado es la fitoterapia(AU)

Introduction: Urolithiasis causes pain, renal functional deterioration and notorious economic expenses. Objectives: To identify the clinical-epidemiological characteristics of nephrolithiasis. Methods: A descriptive, cross-sectional study was conducted in a total of 2,923 people from to three clinics of Plaza de la Revolution Teaching Community Clinic, Plaza de la Revolution municipality, Havana province, Cuba. They were selected by simple random sampling from the 16 clinics that the health area has. The data was obtained through a survey and structured interview. The information was processed automatically (IBMSPSS 22.0). Frequency distribution analysis was used, prevalence rates were calculated and the homogeneity test was used. Results: The prevalence of urolithiasis was 4.99 per 100 inhabitants, 6.3 among men and 5.7 among white-skinned men. The average age at diagnosis was 39.3 years. Among the risk factors for lithiasis, the high intake of oxalates prevailed (97.3 percent). Ultrasound was the most used form of diagnosis (67.8 percent). Phytotherapy was the most used medical treatment (69.2 percent). A medical permit was issued to 16.4 percent of the patients in the last two years. Conclusions: The prevalence of urinary lithiasis in Plaza de la Revolution Teaching Community Clinic is high, prevailing in males, in white-skinned and middle aged subjects. High oxalate intake is the most common risk factor for urinary lithiasis found. The most used form of diagnosis is ultrasound and the most used treatment is phytotherapy(AU)

Unraveling the Dynamic Interfacial Behavior of LiCoO2 at Various Voltages with Lithium Bis(oxalato)borate for Lithium-Ion Batteries.

The electrochemical dynamic behavior of the solid electrolyte interface (SEI) formed on LiCoO2 (LCO) by lithium bis(oxalato)borate (LiBOB) is investigated at various cutoff voltages. Particularly, for layered cathode active materials, various cutoff voltages are used to control the delithiation states; however, systematic investigations of the voltage and SEI are lacking. To increase the practical energy density of the LCO, a high cutoff voltage is pursued to utilize a state of high delithiation. However, this high cutoff voltage causes the electrolyte to undergo side reactions and the crystalline structure changes irreversibly, limiting the cycle life. In a low-voltage environment (<4.7 V), LiBOB improves the initial Coulombic efficiency and cycling performance by forming an effective SEI, which suppresses side reactions. At higher voltage levels (4.7-4.9 V), LiBOB no longer effectively protects the surface, causing the electrochemical performance to decrease rapidly. The main cause of this phenomenon is the decomposition of LiBOB-SEI at a high voltage, as shown by systematic surface and electrochemical analyses comprising linear sweep voltammetry, cyclic voltammetry, and electrochemical impedance spectroscopy. In conclusion, LiBOB can suppress side reactions of the electrolyte by SEI formation, but the SEI decomposes at voltage levels higher than 4.7 V.

Organic-Inorganic Hybrid SEI Induced by a New Lithium Salt for High-Performance Metallic Lithium Anodes.

The practical application of the metallic lithium anode is suppressed by the highly unstable interface between electrolytes and lithium metal during the process of lithium plating/stripping. A perfect solid electrolyte interphase (SEI) can inhibit detrimental parasitic reactions, thereby improving the cycling performance of the metallic lithium anode. In this work, a high-purity solid lithium difluorobis(oxalato) phosphate (LiDFOP) is synthesized and an outstanding organic-inorganic hybrid SEI is obtained in an ether-based electrolyte for the first time induced by LiDFOP. The preferential reduction of LiDFOP can form an SEI rich in LiF and LixPOyFz species, thereby improving the conductivity and stability of the SEI. In addition, cationic-induced ring-opening polymerization between LiDFOP and 1,3-dioxolane endows the SEI with excellent adaptability to the reiterative volume change of the metallic lithium anode. Therefore, the Li/Cu battery maintains a high coulombic efficiency of 98.37% at a current density of 2 mA/cm2 for 200 cycles, and the Li/Li symmetrical battery shows stable voltage hysteresis over 1000 h even under the condition of 5 mA/cm2. The Li/S battery fabricated employing the electrolyte with LiDFOP shows significant improvement of cycling performance as well. These results manifest that the formation of an organic-inorganic hybrid SEI from LiDFOP can be employed as a new strategy to overcome the problem from the unstable SEI in metallic lithium batteries.

Ferro- and Antiferromagnetic Interactions in Oxalato-Centered Inverse Hexanuclear and Chain Copper(II) Complexes with Pyrazole Derivatives.

Two novel copper(II) complexes of formulas {[Cu(4-Hmpz)4][Cu(4-Hmpz)2(µ3-ox-κ2O1,O2:κO2':κO1')(ClO4)2]}n (1) and {[Cu(3,4,5-Htmpz)4]2[Cu(3,4,5-Htmpz)2(µ3-ox-κ2O1,O2:κO2':κO1')(H2O)(ClO4)]2[Cu2(3,4,5-Htmpz)4(µ-ox-κ2O1,O2:κ2O2',O1')]}(ClO4)4·6H2O (2) have been obtained by using 4-methyl-1H-pyrazole (4-Hmpz) and 3,4,5-trimethyl-1H-pyrazole (3,4,5-Htmpz) as terminal ligands and oxalate (ox) as the polyatomic inverse coordination center. The crystal structure of 1 consists of perchlorate counteranions and cationic copper(II) chains with alternating bis(pyrazole)(µ3-κ2O1,O2:κO2':κO1'-oxalato)copper(II) and tetrakis(pyrazole)copper(II) fragments. The crystal structure of 2 is made up of perchlorate counteranions and cationic centrosymmetric hexanuclear complexes where an inner tetrakis(pyrazole)(µ-κ2O1,O2:κ2O2',O1'-oxalato)dicopper(II) entity and two outer mononuclear tetrakis(pyrazole)copper(II) units are linked through two mononuclear aquabis(pyrazole)(µ3-κ2O1,O2:κO2':κO1'-oxalato)copper(II) units. The magnetic properties of 1 and 2 were investigated in the temperature range 2.0-300 K. Very weak intrachain antiferromagnetic interactions between the copper(II) ions through the µ3-ox-κ2O1,O2:κO2':κO1' center occur in 1 [J = -0.42(1) cm-1, the spin Hamiltonian being defined as H = -J∑S1,i · S2,i+1], whereas very weak intramolecular ferromagnetic [J = +0.28(2) cm-1] and strong antiferromagnetic [J' = -348(2) cm-1] couplings coexist in 2 which are mediated by the µ3-ox-κ2O1,O2:κO2':κO1' and µ-ox-κ2O1,O2:κ2O2',O1' centers, respectively. The variation in the nature and magnitude of the magnetic coupling for this pair of oxalato-centered inverse copper(II) complexes is discussed in the light of their different structural features, and a comparison with related oxalato-centered inverse copper(II)-pyrazole systems from the literature is carried out.

[Urinary pH relevance on urolithiasis management.] / Importancia del pH urinario en la urolitiasis.

OBJECTIVE: Urinary pH is a factor that influences in urinary lithogenesis. It can condition the heterogeneous nucleation of calcium oxalate and the crystallization or dissolution of other substances such as uricacid, cystine and phosphates. Its exact and precise measurement is a tool to guide the treatment and prevention. The most accurate way to measure the pH is to use a glass electrode and a pH-meter, but this device is used in hospital's environment and is not portable. Test strips are not adequate for proper measurement. Recently, a portable and electronic device for measuring urinary pH has shown greater precision and accuracy in the measurement of urinary pH, with good acceptance by patients. METHOD: We carried out a bibliographic search inPUBMED and EMBASE using the terms "URINARY pH", "Lithiasis", "Uro-Lihitiasis", "Urinary Stone", "Urinary pH measurement", in order to compile articles, books, abstracts and the most relevant clinical guides in English and Spanish on this topic. RESULTS: We select a total of 66 articles, 3 books, an abstract of a study unpublished presented at the American urology congress and the European Guidelines on urolithiasis on the effect of pH on the formation and prevention of urolithiasis. Four articles deal specifically with the effect of urinary pH on urolithiasis, 5 articles deal with a new portable electronic device for measuring urinary pH, 5 articles dealt with the measurement of urinary pH with test strips and 1 article dealt with the modification of urinary pH to reduce fouling of double J catheters, 2 articles deal about the urinary acidification with oral methionine. The selected abstract deals with the new portable device for measuring urinary pH in cystinuric patients. The 3 selected books have specific sections where the role of urinary pH in urolithiasis is discussed. Finally, in the European Urology Guidelines, the control of urinary pH is emphasized in the sections of prevention of urolithiasis formation, treatment of uric lithiasis, infectious/non-infectious phosphocalcic and cystine. CONCLUSIONS: Urinary pH is a recognized factor in the scientific-urological community for the study, monitoring, treatment and prevention of lithiasic patients. Urinary pH measurement is a very useful tool, but test strips are not suitable for pH measurement and medical decision making. Currently, several studies have evaluated a new device to achieve the measurement of urinary pH effectively and easily by the patient, keeping urinary pH innon-lithogenic ranges with the association of medical and non-medical treatments, and good acceptability from the patients.

OBJETIVO: El pH urinario es un factorque influye en la litogénesis urinaria de forma importante. Puede condicionar la nucleación heterogénea del oxalato de calcio y la cristalización o disolución de otras sustancias como el ácido úrico, cistina y fosfatos. Su medición exacta y precisa es una herramienta para orientar el tratamiento y la prevención. La forma más precisa de medirlo es la utilización de un electrodo de vidrio y un pH-metro, pero este dispositivo es de uso hospitalario y no portátil. Las tiras reactivas no son fiables para una medición adecuada. Recientemente un dispositivo para medir el pH urinario, portátil y electrónico ha demostrado mayor precisión y exactitud en la medición del ph urinario, con buena aceptación por parte de los pacientes.MÉTODO: Realizamos una búsqueda bibliográfica en PUBMED y EMBASE utilizando los términos "URINARYpH", "Lithiasis", "Uro-Lihitiasis", "Urinary Stone", "UrinarypH measurement", con la finalidad de recopilar los artículos, libros, resúmenes y guías clínicas más relevantes en inglés y castellano sobre este tema. RESULTADOS: Recopilamos un total de 66 artículos, 3 libros, un resumen de un estudio presentado en el congreso americano de urología no publicado y las Guías Europeas de uro-litiasis sobre el efecto del pH en la formación y prevención de la litiasis urinaria. Cuatro artículos tratan específicamente sobre el pH urinario en la uro-litiasis, 5 artículos tratan sobre un dispositivo portable y electrónico para la medición del pH urinario, 5 artículos tratan sobre la medición del pH urinario con tiras reactivas. 1 artículo trata sobre la modificación del pH urinario para reducir incrustaciones de los catéteres doble J, 2 artículos tratan sobre la acidificación vía oral mediante metionina. El resumen seleccionado trata sobre el nuevo dispositivo portable para medir el pH urinario en pacientes cistinúricos. Los 3 libros tienen apartados específicos en dónde se comenta el papel del pH urinario en la uro-litiasis. Finalmente, en las Guías Europeas de Urología, se enfatiza el control del pH urinario en los apartados de prevención de formación de litiasis urinaria, tratamiento de litiasis úrica, fosfocálcica infecciosa/no infecciosa y cistina. CONCLUSIONES: El pH urinario es un factor reconocido en la comunidad científica - urológica dentro del estudio, seguimiento, tratamiento y prevención de los pacientes litiásicos. La medición del pH urinario es una herramienta muy útil. Las tiras reactivas no son precisas para la medición del pH y la toma de decisiones médicas. Actualmente diversos estudios han valorado un dispositivo para conseguir la medición del pH urinario de forma efectiva y sencilla por parte del paciente, de forma que se complemente con tratamientos médicos y no médicos para mantener el pH urinario en rangos no litogénicos, con buena aceptabilidad por parte de los pacientes.

Endoscopic identification of urinary stone composition: A study of South Eastern Group for Urolithiasis Research (SEGUR 2). / Identificación endoscópica de la composición de los cálculos urinarios: un estudio del Southeastern Group for Lithiasis Research (SEGUR 2).

INTRODUCTION AND OBJECTIVES: To assess the surgeon's ability to evaluate the composition of the stone by observation of endoscopic images. MATERIALS AND METHODS: A series of 20 video clips of endoscopic treatments of urinary stones of which was also available the result of infrared spectroscopy was uploaded to a YouTube site accessible only to members of the South Eastern Group for Urolithiasis Research (SEGUR) who were asked to identify the composition of the stones. RESULTS: A total of 32 clinicians from 9 different countries participated in the study. The average number of correct detections of participants was 7.81 ± 2.68 (range 1-12). Overall accuracy was 39% (250 out of 640 predictions). Calcium oxalate dihydrate stones have been correctly detected in 69.8%, calcium oxalate monohydrate in 41.8%, uric acid in 33.3%, calcium oxalate/uric acid in 34.3% and cystine in 78.1%. Precision rates for struvite (15.6%), calcium phosphate (0%) and mixed calcium oxalate/calcium phosphate (9.3%) were quite low. CONCLUSIONS: Observation of the stone during the endoscopic procedure was not reliable to identify the composition of most stones although it gave some information allowing to identify with a good sensitivity calcium oxalate dihydrate and cystine stones. Nevertheless, photo or video reporting of the intact stone and its internal structure could should be encouraged to implement results of still mandatory post-operative stone analysis. Endourologists should improve their ability of visual identification of the different types of stones.

[Interpretation of the metabolic study in renal lithiasis and its treatment]. / Interpretación del estudio metabólico en la litiasis renal y su tratamiento.

Urolithiasis is a common disease, and is an important health problem that is associated with a great economic burden. The nature of stone disease varies according by dietary and lifestyle factors, including, among others, climate variations. The majority of patients will suffer a new lithiasic episode at some point in their life, unless preventive measures, such as changing lifestyles and dietary habits, are put in place to avoid it. The risk factors involved in lithogenesis should be evaluated in order to reduce recurrences. In the majority of these patients, metabolic changes are observed in the urine that predispose lithogenesis. The kind of evaluation depends on stone composition and on the clinical presentation. A diagnosis of systemic and renal diseases of lithogenic nature can be diagnosed with these studies, and they also enable the adoption of precise prophylactic measures that achieve control of recurrence in a great number of patients.

Bilateral ureterolithiasis in a 7-month-old cat / Ureterolitíase bilateral em um gato de sete meses de idade

ABSTRACT: Feline ureteral obstruction can have several causes; however, ureterolithiasis has been increasing in occurrence. The restriction of urinary flow induced by the obstruction has harmful consequences to the body and can lead to acute renal failure. Calcium oxalate ureterolithiasis is reported in older cats, aged mean 12 years old. A case of bilateral ureteral obstruction in a 7-month-old mixed breed cat is described in this report. Imaging tests such as abdominal ultrasonography, radiography and excretory urography were performed to determine the diagnosis. The surgical procedure of bilateral ureterotomy was then performed, which allowed the improvement of the urinary flow of both kidneys and the resolution of clinical signs caused by uremia. The quantitative analysis of both uroliths revealed the composition of 100% monohydrate calcium oxalate. Calcium oxalate stones can also cause ureteral obstruction in young cats; although, are less common in this age. When conservative treatment fails, surgical intervention becomes necessary for the rapid return of renal function. To author's knowledge this is the first report of a ureterolithiasis caused by calcium oxalate in a young cat.

RESUMO: A obstrução ureteral em gatos pode ter diversas causas, entretanto, a ureterolitíase vem apresentando um aumento na sua ocorrência. A restrição do fluxo urinário induzida pela obstrução traz consequências graves ao organismo, podendo levar a insuficiência renal aguda. A ureterolitíase por cálculos de oxalato de cálcio é relatada em gatos mais velhos, com média de idade de 12 anos. Um caso de obstrução ureteral bilateral em um gato, SRD, com sete meses de idade é descrito nesse relato. Exames de imagem, como ultrassonografia e radiografia abdominais e urografia excretora, foram realizados para confirmar o diagnóstico. O procedimento cirúrgico de ureterotomia bilateral foi então realizado, permitindo a melhora do fluxo urinário de ambos os rins e dos sinais clínicos de uremia. A análise quantitativa de ambos os urólitos revelou a composição de 100% oxalato de cálcio monohidratado. Cálculos de oxalato de cálcio são um diagnóstico diferencial para obstrução ureteral também em gatos jovens, apesar de serem menos comuns. Quando há falha no tratamento conservador, a intervenção cirúrgica torna-se necessária para o rápido restabelecimento e preservação da função renal. No conhecimento dos autores, esse é o primeiro relato de ureterolitíase causada por oxalato de cálcio em um gato jovem.

Crystal structure of di-ammonium bis-[tris-(oxamide dioxime-κ2 N,N')nickel(II)] bis-[tris-(oxalato-κ2 O,O')chromate(III)] 6.76-hydrate.

The asymmetric unit of the title compound, (NH4)2[Ni(C2H6N4O2)3]2[Cr(C2O4)3]2·6.76H2O, comprises two NH4 + cations, two [Ni(C2H6N4O2)3]2+ cations and two [Cr(C2O4)3]3- anions, as well as eight water mol-ecules of crystallization of which only one is fully occupied. In the cationic and anionic complexes, the central atoms (NiII and CrIII) are each surrounded by three bidentate ligands (N-chelating oxamide dioxime and O-chelating oxalate, respectively), resulting in distorted octa-hedral coordination spheres. In the crystal, O-H⋯O hydrogen bonds between the oxamide dioxime ligands as donor groups and the oxalate ligands as acceptor groups alternately connect the cationic and anionic complexes into infinite pillars extending parallel to [100]. Moreover, N-H⋯O hydrogen bonds between the same ligands connect neighboring pillars, thus delineating channels that accommodate the charge-balancing NH4 + cations as well as the water mol-ecules of crystallization. Although the H atoms could not be localized for these two species, the corresponding N⋯O and O⋯O distances indicate hydrogen bonds of medium strength.